Aronimink Golf Club near Philadelphia is set to host the PGA Championship. This Donald Ross design features challenging par-4s and long par...

Tata Technologies reported 8% year-on-year profit growth in Q4FY26 with strong 22% revenue rise. Improved margins, sequential earnings surg...

Defence stocks are rallying sharply with strong technical breakouts, though select heavyweights signal near-term overbought conditions. Ana...

ICICI Bank sees profit booking after hitting a high in September 2024, but shows signs of bullish momentum. Short-term traders are advised ...

The stock rose from Rs 276 as of May 26, 2023, to Rs 434 on May 26, 2024. The pharma stock hit a record high of Rs 480 on 26th February but...

The stock hit a 52-week high of Rs 275 on November 4, 2022, but failed to hold on to the momentum. It reversed losses after consolidating a...

Although the stock has been rising steadily in the last few months, but a breakdown from a wedge pattern could infuse further weakness whic...

MCX SILVER made a spinning top formation near the trend line resistance of Rs 64,150 which is also a double top zone, indicating a strong s...

Recommend avoiding any purchases following any down move in the market.

Nifty continues to remain precariously trapped in the Rising Wedge formation.

The market is likely to exhibit a cautious and tentative bias throughout the week.

Each move higher from the current level will need to be dealt with a high degree of caution.

The volatility moderately rose as India VIX climbed 2.03 per cent to 43.45.

The market is likely to see a tepid start to Monday’s session.

Pennant is similar to a symmetrical triangle, with a few differences.

Ranbaxy has been moving in a upward rising wedge and has taken resistance at upper trend line of the wedge.

Sharekhan is of the view that Ranbaxy Laboratories has broken down from rising wedge.